| ViraEpi4281 | Epstein barr virus (EBV) | Rp | NA | 106576 | 106576 | Intermediate | 60% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi4282 | Epstein barr virus (EBV) | Rp | NA | 106634 | 106634 | Intermediate | 60% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi4283 | Epstein barr virus (EBV) | Rp | NA | 106647 | 106647 | Intermediate | 60% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi4284 | Epstein barr virus (EBV) | Rp | NA | 106655 | 106655 | No methylation | 0% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi4285 | Epstein barr virus (EBV) | Rp | NA | 106660 | 106660 | Intermediate | 60% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi4286 | Epstein barr virus (EBV) | Rp | NA | 106687 | 106687 | Hyper | 100% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi4287 | Epstein barr virus (EBV) | Rp | NA | 106691 | 106691 | Hyper | 100% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi4288 | Epstein barr virus (EBV) | Rp | NA | 106742 | 106742 | Hypo | 40% | PTLD2 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 |